Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice

Tero Ylisaukko-oja; Saku Torvinen; Jaakko Aaltonen; Heikki Nuutinen; Timo Blomster; Airi Jussila; Markku Pajala; Kimmo Salminen; Veikko Moilanen; Kalle Hakala; Mikko Kellokumpu; Kari Toljamo; Henna Rautiainen; Juha Kuisma; Markku Peräaho; Pauliina Molander; Jouni Silvennoinen; Ville Liukkonen; Hans Henricson; Jyrki Tillonen; Mirva Esterinen; Christian Nielsen; Eija Hirsi; Margus Lääne; Ulla-Maija Suhonen; Ilkka Vihriälä; Petri Makela; Mika Puhto; Jari Punkkinen; Hannu Sulonen; Sauli Herrala; Jari Jokelainen; Klaus Tamminen; Taina Sipponen

doi:10.1016/j.biologicals.2019.01.007

Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice

Tero Ylisaukko-oja, Saku Torvinen, Jaakko Aaltonen, Heikki Nuutinen, Timo Blomster, Airi Jussila, Markku Pajala, Kimmo Salminen, Veikko Moilanen, Kalle Hakala, Mikko Kellokumpu, Kari Toljamo, Henna Rautiainen, Juha Kuisma, Markku Peräaho, Pauliina Molander, Jouni Silvennoinen, Ville Liukkonen, Hans Henricson, Jyrki TillonenMirva Esterinen, Christian Nielsen, Eija Hirsi, Margus Lääne, Ulla-Maija Suhonen, Ilkka Vihriälä, Petri Makela, Mika Puhto, Jari Punkkinen, Hannu Sulonen, Sauli Herrala, Jari Jokelainen, Klaus Tamminen, Taina Sipponen

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Biologicals
Volym	58
Sidor (från-till)	50-56
Antal sidor	7
ISSN	1045-1056
DOI	https://doi.org/10.1016/j.biologicals.2019.01.007
Status	Publicerad - mars 2019
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin

Åtkomst av dokument

10.1016/j.biologicals.2019.01.007

Citera det här

Ylisaukko-oja, T., Torvinen, S., Aaltonen, J., Nuutinen, H., Blomster, T., Jussila, A., Pajala, M., Salminen, K., Moilanen, V., Hakala, K., Kellokumpu, M., Toljamo, K., Rautiainen, H., Kuisma, J., Peräaho, M., Molander, P., Silvennoinen, J., Liukkonen, V., Henricson, H., ... Sipponen, T. (2019). Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice. Biologicals, 58, 50-56. https://doi.org/10.1016/j.biologicals.2019.01.007

@article{faabd49b91a44e6595ace18a08119614,

title = "Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice",

keywords = "Corticosteroid, Immunosuppressive, 5-Aminosalicylic acid, Vedolizumab, Crohn's disease, Ulcerative colitis, Biological therapy, CROHNS-DISEASE, COMBINATION THERAPY, MAINTENANCE THERAPY, IMMUNOMODULATOR USE, ULCERATIVE-COLITIS, INDUCTION, IBD, IMMUNOGENICITY, AZATHIOPRINE, INFLIXIMAB, 3121 General medicine, internal medicine and other clinical medicine",

author = "Tero Ylisaukko-oja and Saku Torvinen and Jaakko Aaltonen and Heikki Nuutinen and Timo Blomster and Airi Jussila and Markku Pajala and Kimmo Salminen and Veikko Moilanen and Kalle Hakala and Mikko Kellokumpu and Kari Toljamo and Henna Rautiainen and Juha Kuisma and Markku Per{\"a}aho and Pauliina Molander and Jouni Silvennoinen and Ville Liukkonen and Hans Henricson and Jyrki Tillonen and Mirva Esterinen and Christian Nielsen and Eija Hirsi and Margus L{\"a}{\"a}ne and Ulla-Maija Suhonen and Ilkka Vihri{\"a}l{\"a} and Petri Makela and Mika Puhto and Jari Punkkinen and Hannu Sulonen and Sauli Herrala and Jari Jokelainen and Klaus Tamminen and Taina Sipponen",

year = "2019",

month = mar,

doi = "10.1016/j.biologicals.2019.01.007",

language = "English",

volume = "58",

pages = "50--56",

journal = "Biologicals",

issn = "1045-1056",

publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",

}

Ylisaukko-oja, T, Torvinen, S, Aaltonen, J, Nuutinen, H, Blomster, T, Jussila, A, Pajala, M, Salminen, K, Moilanen, V, Hakala, K, Kellokumpu, M, Toljamo, K, Rautiainen, H, Kuisma, J, Peräaho, M, Molander, P, Silvennoinen, J, Liukkonen, V, Henricson, H, Tillonen, J, Esterinen, M, Nielsen, C, Hirsi, E, Lääne, M, Suhonen, U-M, Vihriälä, I, Makela, P, Puhto, M, Punkkinen, J, Sulonen, H, Herrala, S, Jokelainen, J, Tamminen, K & Sipponen, T 2019, 'Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice', Biologicals, vol. 58, s. 50-56. https://doi.org/10.1016/j.biologicals.2019.01.007

TY - JOUR

T1 - Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice

AU - Ylisaukko-oja, Tero

AU - Torvinen, Saku

AU - Aaltonen, Jaakko

AU - Nuutinen, Heikki

AU - Blomster, Timo

AU - Jussila, Airi

AU - Pajala, Markku

AU - Salminen, Kimmo

AU - Moilanen, Veikko

AU - Hakala, Kalle

AU - Kellokumpu, Mikko

AU - Toljamo, Kari

AU - Rautiainen, Henna

AU - Kuisma, Juha

AU - Peräaho, Markku

AU - Molander, Pauliina

AU - Silvennoinen, Jouni

AU - Liukkonen, Ville

AU - Henricson, Hans

AU - Tillonen, Jyrki

AU - Esterinen, Mirva

AU - Nielsen, Christian

AU - Hirsi, Eija

AU - Lääne, Margus

AU - Suhonen, Ulla-Maija

AU - Vihriälä, Ilkka

AU - Makela, Petri

AU - Puhto, Mika

AU - Punkkinen, Jari

AU - Sulonen, Hannu

AU - Herrala, Sauli

AU - Jokelainen, Jari

AU - Tamminen, Klaus

AU - Sipponen, Taina

PY - 2019/3

Y1 - 2019/3

KW - Corticosteroid

KW - Immunosuppressive

KW - 5-Aminosalicylic acid

KW - Vedolizumab

KW - Crohn's disease

KW - Ulcerative colitis

KW - Biological therapy

KW - CROHNS-DISEASE

KW - COMBINATION THERAPY

KW - MAINTENANCE THERAPY

KW - IMMUNOMODULATOR USE

KW - ULCERATIVE-COLITIS

KW - INDUCTION

KW - IBD

KW - IMMUNOGENICITY

KW - AZATHIOPRINE

KW - INFLIXIMAB

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1016/j.biologicals.2019.01.007

DO - 10.1016/j.biologicals.2019.01.007

M3 - Article

SN - 1045-1056

VL - 58

SP - 50

EP - 56

JO - Biologicals

JF - Biologicals

ER -